| Brandi Renee Garris, ACNP | |
|
20 Rawls Springs Loop Rd, Hattiesburg, MS 39402-7801 | |
| (601) 582-9553 | |
| (601) 582-9553 |
| Full Name | Brandi Renee Garris |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 18 Years |
| Location | 20 Rawls Springs Loop Rd, Hattiesburg, Mississippi |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073630307 | NPI | - | NPPES |
| P00417383 | Other | MS | RAILROAD MEDICARE |
| 01755393 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LA2100X | Nurse Practitioner - Acute Care | R853120 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Marion General Hospital | Columbia, MS | Hospital |
| Ochsner Medical Center-hancock | Bay saint louis, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Keystone Hospitalist Services Of Ms Inc | 7517103864 | 22 |
| Hancock Emergency Group Llc | 8022237015 | 15 |
News Archive
Akela Pharma, Inc., a leader in the development of therapeutics for the treatment of pain, and the company's wholly owned subsidiary, PharmaForm, today that it has today filed a restated Management Discussion and Analysis ("MD&A) for the fiscal year ended 2008.
Glyxambi® (empagliflozin/linagliptin) tablets are now available by prescription in many leading chain and independent pharmacies across the U.S., including Walgreens and Rite Aid.
Diabetic kidney disease, which affects between 20 to 40 percent of people with diabetes, is a serious complication that can ultimately lead to end-stage kidney disease-a life-threatening condition that requires either dialysis or kidney transplant.
In this post in BMJ's "Yankee Doodling," Douglas Kamerow, chief scientist at RTI International and an associate editor for the journal, reflects on the possibility of achieving an AIDS-free generation "if somehow we succeeded in getting all HIV positive people in the world identified and under long term treatment."
› Verified 3 days ago
| Entity Name | Keystone Medical Services Of Ms Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174691059 PECOS PAC ID: 7618075177 Enrollment ID: O20070606000447 |
News Archive
Akela Pharma, Inc., a leader in the development of therapeutics for the treatment of pain, and the company's wholly owned subsidiary, PharmaForm, today that it has today filed a restated Management Discussion and Analysis ("MD&A) for the fiscal year ended 2008.
Glyxambi® (empagliflozin/linagliptin) tablets are now available by prescription in many leading chain and independent pharmacies across the U.S., including Walgreens and Rite Aid.
Diabetic kidney disease, which affects between 20 to 40 percent of people with diabetes, is a serious complication that can ultimately lead to end-stage kidney disease-a life-threatening condition that requires either dialysis or kidney transplant.
In this post in BMJ's "Yankee Doodling," Douglas Kamerow, chief scientist at RTI International and an associate editor for the journal, reflects on the possibility of achieving an AIDS-free generation "if somehow we succeeded in getting all HIV positive people in the world identified and under long term treatment."
› Verified 3 days ago
| Entity Name | Keystone Hospitalist Services Of Ms Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932447968 PECOS PAC ID: 7517103864 Enrollment ID: O20130411000527 |
News Archive
Akela Pharma, Inc., a leader in the development of therapeutics for the treatment of pain, and the company's wholly owned subsidiary, PharmaForm, today that it has today filed a restated Management Discussion and Analysis ("MD&A) for the fiscal year ended 2008.
Glyxambi® (empagliflozin/linagliptin) tablets are now available by prescription in many leading chain and independent pharmacies across the U.S., including Walgreens and Rite Aid.
Diabetic kidney disease, which affects between 20 to 40 percent of people with diabetes, is a serious complication that can ultimately lead to end-stage kidney disease-a life-threatening condition that requires either dialysis or kidney transplant.
In this post in BMJ's "Yankee Doodling," Douglas Kamerow, chief scientist at RTI International and an associate editor for the journal, reflects on the possibility of achieving an AIDS-free generation "if somehow we succeeded in getting all HIV positive people in the world identified and under long term treatment."
› Verified 3 days ago
| Entity Name | Hancock Emergency Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295142396 PECOS PAC ID: 8022237015 Enrollment ID: O20140924002285 |
News Archive
Akela Pharma, Inc., a leader in the development of therapeutics for the treatment of pain, and the company's wholly owned subsidiary, PharmaForm, today that it has today filed a restated Management Discussion and Analysis ("MD&A) for the fiscal year ended 2008.
Glyxambi® (empagliflozin/linagliptin) tablets are now available by prescription in many leading chain and independent pharmacies across the U.S., including Walgreens and Rite Aid.
Diabetic kidney disease, which affects between 20 to 40 percent of people with diabetes, is a serious complication that can ultimately lead to end-stage kidney disease-a life-threatening condition that requires either dialysis or kidney transplant.
In this post in BMJ's "Yankee Doodling," Douglas Kamerow, chief scientist at RTI International and an associate editor for the journal, reflects on the possibility of achieving an AIDS-free generation "if somehow we succeeded in getting all HIV positive people in the world identified and under long term treatment."
› Verified 3 days ago
| Entity Name | Relias Emergency Medicine Specialists Of Hattiesburg Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609409440 PECOS PAC ID: 9032549142 Enrollment ID: O20200413002970 |
News Archive
Akela Pharma, Inc., a leader in the development of therapeutics for the treatment of pain, and the company's wholly owned subsidiary, PharmaForm, today that it has today filed a restated Management Discussion and Analysis ("MD&A) for the fiscal year ended 2008.
Glyxambi® (empagliflozin/linagliptin) tablets are now available by prescription in many leading chain and independent pharmacies across the U.S., including Walgreens and Rite Aid.
Diabetic kidney disease, which affects between 20 to 40 percent of people with diabetes, is a serious complication that can ultimately lead to end-stage kidney disease-a life-threatening condition that requires either dialysis or kidney transplant.
In this post in BMJ's "Yankee Doodling," Douglas Kamerow, chief scientist at RTI International and an associate editor for the journal, reflects on the possibility of achieving an AIDS-free generation "if somehow we succeeded in getting all HIV positive people in the world identified and under long term treatment."
› Verified 3 days ago
| Entity Name | Singing River Gulfport |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861010159 PECOS PAC ID: 5294154829 Enrollment ID: O20201001001497 |
News Archive
Akela Pharma, Inc., a leader in the development of therapeutics for the treatment of pain, and the company's wholly owned subsidiary, PharmaForm, today that it has today filed a restated Management Discussion and Analysis ("MD&A) for the fiscal year ended 2008.
Glyxambi® (empagliflozin/linagliptin) tablets are now available by prescription in many leading chain and independent pharmacies across the U.S., including Walgreens and Rite Aid.
Diabetic kidney disease, which affects between 20 to 40 percent of people with diabetes, is a serious complication that can ultimately lead to end-stage kidney disease-a life-threatening condition that requires either dialysis or kidney transplant.
In this post in BMJ's "Yankee Doodling," Douglas Kamerow, chief scientist at RTI International and an associate editor for the journal, reflects on the possibility of achieving an AIDS-free generation "if somehow we succeeded in getting all HIV positive people in the world identified and under long term treatment."
› Verified 3 days ago
| Entity Name | Rh Emergency Medicine Of Marion General Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841064110 PECOS PAC ID: 0648623744 Enrollment ID: O20240124004763 |
News Archive
Akela Pharma, Inc., a leader in the development of therapeutics for the treatment of pain, and the company's wholly owned subsidiary, PharmaForm, today that it has today filed a restated Management Discussion and Analysis ("MD&A) for the fiscal year ended 2008.
Glyxambi® (empagliflozin/linagliptin) tablets are now available by prescription in many leading chain and independent pharmacies across the U.S., including Walgreens and Rite Aid.
Diabetic kidney disease, which affects between 20 to 40 percent of people with diabetes, is a serious complication that can ultimately lead to end-stage kidney disease-a life-threatening condition that requires either dialysis or kidney transplant.
In this post in BMJ's "Yankee Doodling," Douglas Kamerow, chief scientist at RTI International and an associate editor for the journal, reflects on the possibility of achieving an AIDS-free generation "if somehow we succeeded in getting all HIV positive people in the world identified and under long term treatment."
› Verified 3 days ago
| Entity Name | Rh Hospitalist Medicine Of Marion General Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801660170 PECOS PAC ID: 2567815384 Enrollment ID: O20240129002254 |
News Archive
Akela Pharma, Inc., a leader in the development of therapeutics for the treatment of pain, and the company's wholly owned subsidiary, PharmaForm, today that it has today filed a restated Management Discussion and Analysis ("MD&A) for the fiscal year ended 2008.
Glyxambi® (empagliflozin/linagliptin) tablets are now available by prescription in many leading chain and independent pharmacies across the U.S., including Walgreens and Rite Aid.
Diabetic kidney disease, which affects between 20 to 40 percent of people with diabetes, is a serious complication that can ultimately lead to end-stage kidney disease-a life-threatening condition that requires either dialysis or kidney transplant.
In this post in BMJ's "Yankee Doodling," Douglas Kamerow, chief scientist at RTI International and an associate editor for the journal, reflects on the possibility of achieving an AIDS-free generation "if somehow we succeeded in getting all HIV positive people in the world identified and under long term treatment."
› Verified 3 days ago
| Entity Name | Rh Emergency Medicine Of Highland Community Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033987946 PECOS PAC ID: 4587017918 Enrollment ID: O20240201000844 |
News Archive
Akela Pharma, Inc., a leader in the development of therapeutics for the treatment of pain, and the company's wholly owned subsidiary, PharmaForm, today that it has today filed a restated Management Discussion and Analysis ("MD&A) for the fiscal year ended 2008.
Glyxambi® (empagliflozin/linagliptin) tablets are now available by prescription in many leading chain and independent pharmacies across the U.S., including Walgreens and Rite Aid.
Diabetic kidney disease, which affects between 20 to 40 percent of people with diabetes, is a serious complication that can ultimately lead to end-stage kidney disease-a life-threatening condition that requires either dialysis or kidney transplant.
In this post in BMJ's "Yankee Doodling," Douglas Kamerow, chief scientist at RTI International and an associate editor for the journal, reflects on the possibility of achieving an AIDS-free generation "if somehow we succeeded in getting all HIV positive people in the world identified and under long term treatment."
› Verified 3 days ago
| Entity Name | Rh Hospitalist Medicine Of Highland Community Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841068756 PECOS PAC ID: 8022451038 Enrollment ID: O20240207000363 |
News Archive
Akela Pharma, Inc., a leader in the development of therapeutics for the treatment of pain, and the company's wholly owned subsidiary, PharmaForm, today that it has today filed a restated Management Discussion and Analysis ("MD&A) for the fiscal year ended 2008.
Glyxambi® (empagliflozin/linagliptin) tablets are now available by prescription in many leading chain and independent pharmacies across the U.S., including Walgreens and Rite Aid.
Diabetic kidney disease, which affects between 20 to 40 percent of people with diabetes, is a serious complication that can ultimately lead to end-stage kidney disease-a life-threatening condition that requires either dialysis or kidney transplant.
In this post in BMJ's "Yankee Doodling," Douglas Kamerow, chief scientist at RTI International and an associate editor for the journal, reflects on the possibility of achieving an AIDS-free generation "if somehow we succeeded in getting all HIV positive people in the world identified and under long term treatment."
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brandi Renee Garris, ACNP 20 Rawls Springs Loop Rd, Hattiesburg, MS 39402-7801 Ph: (601) 582-9553 | Brandi Renee Garris, ACNP 20 Rawls Springs Loop Rd, Hattiesburg, MS 39402-7801 Ph: (601) 582-9553 |
News Archive
Akela Pharma, Inc., a leader in the development of therapeutics for the treatment of pain, and the company's wholly owned subsidiary, PharmaForm, today that it has today filed a restated Management Discussion and Analysis ("MD&A) for the fiscal year ended 2008.
Glyxambi® (empagliflozin/linagliptin) tablets are now available by prescription in many leading chain and independent pharmacies across the U.S., including Walgreens and Rite Aid.
Diabetic kidney disease, which affects between 20 to 40 percent of people with diabetes, is a serious complication that can ultimately lead to end-stage kidney disease-a life-threatening condition that requires either dialysis or kidney transplant.
In this post in BMJ's "Yankee Doodling," Douglas Kamerow, chief scientist at RTI International and an associate editor for the journal, reflects on the possibility of achieving an AIDS-free generation "if somehow we succeeded in getting all HIV positive people in the world identified and under long term treatment."
› Verified 3 days ago
Mrs. Lisa Deloris Slade, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 605 Stadium Dr, Hattiesburg, MS 39401 Phone: 601-450-0310 Fax: 601-450-0321 | |
Lyndell Sue Lee, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 6051 Highway 49, Hattiesburg, MS 39401 Phone: 601-288-7000 | |
Ms. Laura Claire Singley, WHNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 62 Old Airport Rd, Hattiesburg, MS 39401 Phone: 601-544-4500 | |
Kisha L Knight, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 404 Lillie Burney St, Hattiesburg, MS 39401 Phone: 601-450-6500 Fax: 601-450-6503 | |
Melissa Ruth Tolar, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 6051 U S Highway 49, Hattiesburg, MS 39401 Phone: 601-288-1212 | |
Miss Felicia Nicole Smith, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 58 Hawthorne Dr, Hattiesburg, MS 39402 Phone: 662-315-0755 | |
Mrs. Kristen Sentell, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 301 S 28th Ave, Hattiesburg, MS 39401 Phone: 601-288-1700 |